| Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932) |
|---|
| 06/26/2007 | US7235675 Conjugates of mycophenolic acid |
| 06/26/2007 | US7235538 Heterocyclic compounds, which are inhibitors of the enzyme DPP-IV |
| 06/21/2007 | WO2007070872A1 Kinase inhibitors and their uses |
| 06/21/2007 | WO2007069924A1 Deazapurine analogs of 4'-aza-l-nucleosides |
| 06/21/2007 | WO2007069923A1 Deazapurine analogs of 1'-aza-l-nucleosides |
| 06/21/2007 | WO2007069290A1 Process for producing 3,7(9)-dihydro-1h-purine-2,6-dithione compound |
| 06/21/2007 | US20070142631 Enzyme inhibiton immunoassay |
| 06/21/2007 | US20070142405 Bicyclic heterocyclic p-38 kinase inhibitors |
| 06/21/2007 | US20070142402 Kinase Inhibitors And Their Uses |
| 06/21/2007 | US20070142381 Calcium receptor modulating agents |
| 06/21/2007 | DE60125036T2 Hydroxyformamidin-derivate und diese enthaltende medikamente Hydroxyformamidin derivatives and containing the same drug |
| 06/21/2007 | CA2633035A1 Kinase inhibitors and their uses |
| 06/20/2007 | EP1798225A1 Nucleoside analogues or salts thereof |
| 06/20/2007 | EP1797093A1 Novel 3-methyl-7-butinyl-xanthines, production thereof, and use thereof as medicaments |
| 06/20/2007 | EP1797092A1 2-substituted-6-trifluoromethyl purine derivatives with adenosine-a3 antagonistic activity |
| 06/20/2007 | EP1797084A1 NOVEL HETEROCYCLIC NF-kB INHIBITORS |
| 06/20/2007 | CN1984660A 4-arylamino-quinazolines as activators of aspartic acid specificity cysteine protease and inducers of apoptosis |
| 06/14/2007 | WO2007067071A1 Dioxolane derivates for the treatment of cancer |
| 06/14/2007 | WO2007065595A2 Xanthine derivatives, processes for preparing them and their uses |
| 06/14/2007 | WO2007047401A3 A1 adenosine receptor agonists |
| 06/14/2007 | WO2006099379A3 Benzazole derivatives, compositions, and methods of use as b-secretase inhibitors |
| 06/14/2007 | US20070135636 Use of cyclic bioisosters of purine system derivatives for treating diseases produced by disorders of niterergic and dopaminergic systems |
| 06/14/2007 | US20070135505 Aralkyl ester soft drugs |
| 06/14/2007 | US20070135456 8-chloro-3-pentyl-3,7-dihydro-1H-purine-2,6-dione: hyperlipoproteinaemia, dyslipidaemia, heart failure, hypercholesteraemia, atherosclerosis, arteriosclerosis, and hypertriglyceridaemia |
| 06/14/2007 | US20070135454 Bicyclic pyrimidin-4(3h)-ones and analogues and derivatives thereof which modulate the function of the vanilloid-1-receptor(vr1) |
| 06/14/2007 | US20070135451 Imidazo[1,2-a]Pyridine Derivatives for Treatment Of Herpes Viral Infections |
| 06/14/2007 | US20070135443 Novel tyrosine kinase inhibitors |
| 06/14/2007 | US20070135436 Chemical compounds |
| 06/14/2007 | US20070134729 Novel antibacterial agents |
| 06/14/2007 | CA2632280A1 Dioxolane derivates for the treatment of cancer |
| 06/14/2007 | CA2631885A1 Xanthine derivatives, processes for preparing them and their uses |
| 06/13/2007 | EP1794162A1 Purine derivatives as a3 and a1 adenosine receptor agonists |
| 06/13/2007 | EP1375502B1 Process for producing 2,6-dihalogenopurine |
| 06/13/2007 | CN1980930A 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and the use in the form of a DPP-IV inhibitor |
| 06/13/2007 | CN1980929A 4-substituted piperidine derivatives |
| 06/12/2007 | US7230102 Derivatives of triazolyl-imidazopyridine and of the triazolylpurines useful as ligandsof the adenosine a2a receptor and their use as medicaments |
| 06/12/2007 | US7230001 Arylalkane, arylalkene and aryl azaalkane, medicaments containing said compounds and method for the production thereof |
| 06/12/2007 | US7229981 Process for the preparation of aminoalcohol derivatives and their further conversion to (1R,4S)-4-(2-amino-6-chloro-5-formamido-4-pyrimidinyl)-amino)-2-cyclopentenyl-1-methanol |
| 06/12/2007 | CA2366624C 2-hydroxy methylcyclopro pylidenemethyl purines and -pyrimidines as antiviral agents |
| 06/12/2007 | CA2130828C Non-azo naphthalimide dyes and uses for same |
| 06/07/2007 | WO2007025090A3 Heterobicyclic and - tricyclic inhibitors of mapk/erk kinase |
| 06/07/2007 | US20070129386 Multiple sclerosis; hemorrhagic virus infection, autoimmune diseases, autograft rejection, neoplasm, hyperhomocysteineuria, cardiovascular disease, stroke, Alzheimer's disease, or diabetes; can be used in combination with an anti-hemorrhagic viral infection agent, immunosuppressant |
| 06/07/2007 | US20070129385 Amorphous valganciclovir hydrochloride |
| 06/07/2007 | US20070129334 Orally Active Purine-Based Inhibitors of Heat Shock Protein 90 |
| 06/06/2007 | EP1791844A1 8-(3-amino-piperidin-1-yl)-7-(but-2-inyl)-xanthines, production thereof and use thereof as medicaments |
| 06/06/2007 | EP1423389B1 Pyrazolo-pyridines for the treatment of herpes infections |
| 06/06/2007 | CN1976933A Method for reducing residual alcohols in crystalline valacyclovir hydrochloride |
| 06/06/2007 | CN1976905A Pyrimidine derivatives and methods of treatment related to the use thereof |
| 06/06/2007 | CN1319972C Method for reducing residual alcohols in crystalline valacyclovir hydrochloride |
| 05/31/2007 | WO2007060886A1 Therapeutic agent for neurodegenerative disease |
| 05/31/2007 | WO2007037518A9 Mutilin derivative and pharmaceutical composition containing the same |
| 05/31/2007 | WO2007030438A3 Aminopurine derivatives for treating neurodegenerative diseases |
| 05/31/2007 | US20070123545 (1R,4S) or (1S,4R)-1-Amino-4-(hydroxymethyl)-2-cyclopentene D- or L-hydrogen tartrate intermediates |
| 05/30/2007 | EP1790651A1 A1 adenosine receptor antagonists |
| 05/30/2007 | EP1790344A2 Methods for treatment of disease-induced peripheral neuropathy and related conditions |
| 05/30/2007 | EP1648895B1 Metabolite of xanthine phosphodiesterase 5 inhibitor and derivatives thereof useful for treatment of erectile dysfunction |
| 05/30/2007 | EP1318814B1 Triazole compounds useful as protein kinase inhibitors |
| 05/30/2007 | CN1972945A Selective antagonists of A2A adenosine receptors |
| 05/29/2007 | US7223759 N-(4-(2,2-difluoro-benzo(1,3)dioxol-5-ylcarbamoyl)-3-hydroxy-phenyl)-4,6-Bis-((3R,5S)-3,5-diamino-piperidin-1-yl)-(1,3,5)triazine-2-amine for example; Gram-positive and Gram-negative strains; retains potency against common antibiotic resistant strains |
| 05/24/2007 | WO2007058336A1 SCREENING METHOD AND IDENTIFICATION METHOD FOR SUBSTANCE CAPABLE OF INHIBITING DEGRANULATION REACTION OR PROSTAGLANDIN D2 PRODUCTION IN MAST CELL THROUGH Rec168, AND THERAPEUTIC AGENT FOR INFLAMMATORY DISEASE COMPRISING THE SUBSTANCE |
| 05/24/2007 | WO2007056846A1 Azacyclohexane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 05/24/2007 | CA2628996A1 Azacyclohexane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 05/23/2007 | CN1968691A Composition for acceleration of alcohol metabolism or recuperation from fatigue through gluconeogenesis |
| 05/23/2007 | CN1966505A Imidazole [1,2-alpha] purine derivative, method of producing same and use thereof |
| 05/23/2007 | CN1966504A Guanine one-pot synthesis method |
| 05/23/2007 | CN1317281C Production technology of natural 1,3,7,9-tetra methyl uric acid |
| 05/22/2007 | US7220769 Azolylbenzamides and analogues and their use for treating osteoporosis |
| 05/22/2007 | US7220757 Topically administering to the patient an antibacterially effective amount compounds such as N-(4,5-Dibromothien-2-ylmethyl)-N'-(1H-imidazo[4,5-b]pyridine-2-yl)-propane-1,3-diamine for therapy of bacterial infection |
| 05/22/2007 | CA2276694C New fatty acid derivatives |
| 05/18/2007 | WO2007055170A1 Nucleic acid base having perfluoroalkyl group and method for producing the same |
| 05/18/2007 | CA2631129A1 Nucleobase having perfluoroalkyl group and process for producing the same |
| 05/17/2007 | US20070112193 Valacyclovir process |
| 05/17/2007 | US20070111997 Triazolopyrimidines and related analogs as HSP90-inhibitors |
| 05/17/2007 | US20070111996 Pyrazolopyrimidines and related analogs as HSP90-inhibitors |
| 05/16/2007 | EP1115405B1 Use of tnf-alpha inhibitors for treating nerve root injury |
| 05/16/2007 | CN1964972A Process for the preparation of entecavir and novel intermediates thereof via carbon-silicon oxidation |
| 05/16/2007 | CN1315830C Substituted purine new compound with anti-HIV activity, preparing method and use |
| 05/15/2007 | US7217722 Nitrogen-containing compounds having kinase inhibitory activity and drugs containing the same |
| 05/15/2007 | US7217720 Benzimidazolyl- or N-hetero analog derivatives of 4-aza-5 alpha -androstan-3-ones, e.g., beta -(1H-imidazo[4,5-c]pyridin-2-yl)-4-methyl-4-aza-5 alpha -androst-1-en-3-one; treatment of conditions caused by androgen deficiency |
| 05/15/2007 | US7217716 Such as 4-((methyl-pyrimidin-2-ylamino)-methyl)-piperidine-1-carboxylic acid benzyl ester; useful for pain relief; treating migraine, depression, anxiety, schizophrenia, Parkinson's disease, and stroke; N-methyl-D-aspartate NR2B antagonists |
| 05/15/2007 | US7217702 Adenine derivatives, especially substituted with an alkynylene-, alkenylene-, alkadienylene- or alkynylenealkenylene- group; e.g., 2-{3-[1-(Methoxycarbanoyl)piperidin-4-yl]propyn-1-yl}-9-propargyladenine; stimulating motor activity without dyskinesia; treating Huntington's & Parkinson's diseases, etc. |
| 05/10/2007 | WO2007013645A8 Valacyclovir precursor, valacyclovir and salts thereof, and process for the production of them |
| 05/10/2007 | US20070106041 Molecularly imprinted polymer obtainable by polymerization of hexamethyl phosphonamide based monomer in presence of a template molecule and extraction; crosslinking; separation of enantiomers, resolution, used for separation of enantiomers, diastereomers of the template molecule, separation of template |
| 05/10/2007 | US20070105879 Ready-for-use injectable solution of 9-((1,3-dihydroxypropan-2-iloxy)methyl)-2-amine-1h-purin-6(9h)-one, sterile, stable; closed system for packing the solution, process for eliminating alkaline residuals of 9-((1,3-dihydroxypropan-2-iloxy)methyl)-2-amine-1h-purin-6 (9h)-one crystals; pharmaceutical presentation as a closed system ready-for-use; uses and methods |
| 05/10/2007 | US20070105821 Acetylation of a 5,6-diamino-1H-pyrimidine-2,4-dione in an aprotic solvent in the presence of a base; selective antagonists of A2B adenosine receptors |
| 05/09/2007 | EP1781658A1 Imidazoý4,5-d¨pyrimidines, their uses and methods of preparation |
| 05/09/2007 | EP1781657A2 Medicaments with hm74a receptor activity |
| 05/09/2007 | CN1314685C Production method of 2,6-dihalopurine |
| 05/08/2007 | US7214710 Permeable, water soluble, non-irritating prodrugs of chemotherapeutic agents with oxaalkanoic acids |
| 05/08/2007 | US7214665 2-propynyl adenosine analogs having A2A agonist activity and compositions thereof |
| 05/08/2007 | CA2228492C Bicyclic 4-aralkylaminopyrimidine derivatives as tyrosine kinase inhibitors |
| 05/08/2007 | CA2207120C Use of theophylline derivatives for the treatment and prophylaxis of states of shock, novel xanthine compounds and processes for their preparation |
| 05/03/2007 | WO2007049736A1 Concentration crystallizer and method |
| 05/03/2007 | US20070099871 Bioreductively-activated prodrugs |
| 05/02/2007 | EP1778690A1 Substituted 8-aminoalkoxi-xanthines, method for the production thereof and use thereof as medicaments |
| 05/02/2007 | EP1778689A1 Substituted 8-aminoalkylthio-xanthines, and the use thereof as inhibitors of the dipeptidyl peptidase iv |
| 05/02/2007 | EP1537111B1 Hetereoaryl nitrile derivatives |
| 05/02/2007 | CN1956989A Purine derivative |
| 05/02/2007 | CN1955182A Purine compound and use as cannabinoid receptor ligands |
| 05/02/2007 | CN1955181A Purine compound and use as cannabinoid receptor ligands |